Pharma Industry Consortium Completes Brain Wave Study of Ketamine Effects on Healthy Volunteers

LOUISVILLE, Ky., March 1, 2023 /PRNewswire/ — The ERP Biomarker Qualification Consortium announced today the successful completion of a pharma industry-sponsored study to measure the electrophysiologic effects of ketamine on healthy brain function. Pharma Industry Consortium Completes…

Leave a Reply

Your email address will not be published. Required fields are marked *